MedTech firm Surgical Planning Associates received FDA 510(k) clearance for its HipInsight 2.0 mixed reality guidance system for hip arthroplasty.
HipInsight 2.0 uses mixed reality display eyeglass lenses to give surgeons "X-ray vision," allowing them to see detailed three-dimensional information in and around the patient's hip joint.
The system can overlay digital content onto the patient, generate "future X-rays" in advance, and project them onto actual intraoperative X-rays for live comparison during surgery.
Analyst QuickTake: The news follows the company’s milestone of using HipInsight for 3,000 total hip replacement cases in February 2024 . Other MedTech firms that have recently received FDA clearance for their products include pre-operative planning workflow platform ImmersiveTouch ( July 2024 ) and AR medical imaging platform ( February 2024 ).
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.